Health watchdog makes U-turn over arthritis drug
Friday 02 July 2010
A new arthritis drug is likely to be made available to NHS patients in England and Wales after a U-turn by experts, it was revealed today.
The National Institute for Health and Clinical Excellence (Nice) produced draft guidance recommending the use of tocilizumab as a "last resort" treatment for rheumatoid arthritis patients. Earlier guidance published in March had rejected the drug because it was not considered cost-effective. The change of heart came after the health watchdog obtained new data from the medicine's manufacturer, Roche.
Tocilizumab, which is marketed as RoActemra, is already offered on the NHS in Scotland. The drug costs £10,000 per patient per year and works by targeting the immune system. It can help reduce inflammation of the joints caused by rheumatoid arthritis and prevent long-term damage.
The Nice guidance recommends offering tocilizumab to patients with moderate to severe symptoms who have failed to respond to other treatments.
The decision is still subject to appeal, but Neil Betteridge, the chief executive of charity Arthritis Care, described the move as an "important breakthrough".
Around 700,000 people in the UK suffer from rheumatoid arthritis, an auto-immune disease that attacks the joints.
Life & Style blogs
Watching TV after work makes you feel 'guilty and like a failure'
NHS medics are being lured away to Australia by more money, status and sunshine, survey suggests
Xiaomi Mi4: 'Chinese Apple' launches flagship mobile to challenge iPhone
Have sex with your iPad thanks to the new sex toy no-one asked for
Condom couture: Latex dresses hit the catwalk to raise awareness for HIV and Aids
- 1 Is Gideon Levy the most hated man in Israel or just the most heroic?
- 2 Students offered grants if they tweet pro-Israeli propaganda
- 3 Satellite full of sexually experimental geckos adrift in space, Russia loses control of mission
- 4 Exclusive: Cameron’s Big Society in tatters as charity watchdog launches investigation into claims of Government funding misuse
- 5 Israel has discovered that it's no longer so easy to get away with murder in the age of social media
Highly Competitive Salary: Austen Lloyd: MANCHESTER - Senior Employment Solici...
£600 - £650 per day: Orgtel: Conduct Risk Liaison Manager - Banking - London -...
Highly Attractive Package: Austen Lloyd: CITY - COMMERCIAL LITIGATION - GLOBAL...
£65000 - £75000 per annum + Benefits: Progressive Recruitment: The client is a...